Persistent tachypnea of infancy (PTI) is the most common interstitial lung disease in young children. As no standardized therapeutic guidelines exist, different pharmaceuticals are used to treat PTI; inhaled corticosteroids (ICS) and bronchodilators being mostly used. This observation assessed the effectiveness of bronchodilators and ICS in children with PTI enrolled in the children's interstitial lung diseases (chILD)-EU Register.

中文翻译：

---

吸入支气管扩张剂和皮质类固醇改善婴儿持续性呼吸急促的临床过程

婴儿持续性呼吸急促 (PTI) 是幼儿中最常见的间质性肺病。由于不存在标准化的治疗指南，因此使用不同的药物来治疗 PTI；主要使用吸入性皮质类固醇 (ICS) 和支气管扩张剂。该观察结果评估了支气管扩张剂和 ICS 对加入儿童间质性肺病 (chILD)-欧盟登记册的 PTI 儿童的有效性。